Onconetix announces closing of warrant exercise for $1.11 million gross proceeds

Cincinnati, july 15, 2024 (globe newswire) -- onconetix, inc. (“onconetix” or the “company”) (nasdaq: onco), today announced the closing of the previously announced exercise of certain existing warrants to purchase 7,458,642 shares of its common stock having exercise prices ranging from $1.09 to $2.546 per share, at a reduced exercise price of $0.15 per share. the aggregate gross proceeds from the exercise of the existing warrants were approximately $1.11 million, before deducting placement agent fees and other offering expenses payable by the company.
ONCO Ratings Summary
ONCO Quant Ranking